EverSource Wealth Advisors
KMTS icon

EverSource Wealth Advisors’s Kestra Medical Technologies KMTS Stock Holding History

EverSource Wealth Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57K Buy
101
+25
+33% +$523 ﹤0.01% 3620
2026
Q1 		$1.52K Buy
76
+11
+17% +$259 ﹤0.01% 3734
2025
Q4 		$1.72K Hold
65
– – ﹤0.01% 3547
2025
Q3 		$1.54K Buy
+65
New +$1.16K ﹤0.01% 3609

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EverSource Wealth Advisors's KMTS Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Kestra Medical Technologies (KMTS) stake by 33% in Q2 2026, buying an estimated $523 and bringing the position to 101 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

EverSource Wealth Advisors first reported a position in KMTS in Q3 2025 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • EverSource Wealth Advisors held 101 shares of Kestra Medical Technologies worth $2.57K as of Q2 2026.
  • EverSource Wealth Advisors bought 25 Kestra Medical Technologies shares in Q2 2026, an estimated $523.
  • Kestra Medical Technologies made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3620 holding.
  • EverSource Wealth Advisors first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 4 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.